Rapid communication Open Access
Like 0


On 21 November 2022, a wild poliovirus type 3 (WPV3) was isolated from an environmental surveillance sample of poliovirus essential facilities in the Netherlands. All 51 employees with access to this strain were screened for ongoing or recent poliovirus infection. One employee shedding WPV3 was identified on 8 December and placed in isolation; monitoring and contact tracing were initiated. WPV3 shedding continued for 4 weeks and stopped 5 January 2023. Isolation was lifted 11 January and no further transmission was detected.


Article metrics loading...

Loading full text...

Full text loading...



  1. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Accidentele blootstelling polio, Bijlage bij LCI-draaiboek polio. [Accidental polio exposure. Annex to LCI polio roadmap, Version: December 2020]. Bilthoven: RIVM; 2020. Available from: https://lci.rivm.nl/sites/default/files/2020-12/Bijlage%20Accidentele%20blootstelling%20polio.pdf
  2. World Health Organization (WHO). Public Health Management of Facility Related Exposure to Live Polioviruses. Guidance in managing exposed persons for countries hosting facilities that maintain live polioviruses. Geneva: WHO; 2019. Available from: https://polioeradication.org/wp-content/uploads/2016/07/Public-Health-Management-of-a-facility-PV-exposure.pdf
  3. Duizer E, Ruijs WL, van der Weijden CP, Timen A. Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill. 2017;22(21):30542.  https://doi.org/10.2807/1560-7917.ES.2017.22.21.30542  PMID: 28597830 
  4. World Health Organization (WHO). WHO Global Action Plan for Poliovirus Containment. GAPIV. Geneva: WHO; 2022. Available from: https://polioeradication.org/wp-content/uploads/2022/07/WHO-Global-Action-Plan-for-Poliovirus-Containment-GAPIV.pdf
  5. World Health Organization (WHO). WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use, GAPIII. Geneva: WHO; 2014. Available from: https://polioeradication.org/wp-content/uploads/2016/12/GAPIII_2014.pdf
  6. World Health Organization (WHO). Polio laboratory manual, 4th ed. Geneva: WHO; 2004. Available from: https://apps.who.int/iris/handle/10665/68762
  7. Cardemil CV, Rathee M, Gary H, Wannemuehler K, Anand A, Mach O, et al. Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000-2010. Epidemiol Infect. 2014;142(1):163-71.  https://doi.org/10.1017/S0950268813000800  PMID: 23594458 
  8. Global Polio Eradication Initiative. S1. Supplement to the WHO Polio Laboratory Manual; An alternative test algorithm for poliovirus isolation and characterization. Geneva: WHO; 2017. Available from: https://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error